On Demand Webinar: Using Rapid NGS Testing for Trial Assignment in the NCI Precision Medicine Initiative in AML and MDS (myeloMATCH)

NCI has validated Genexus and NCI Myeloid Assay for investigational use within the myeloMATCH study in the US. Genexus Integrated Sequencer(RUO) is currently available in the North America and rest of the world for research use only. Not for use in diagnostic procedures. For other clinical trial programs, please reference and seek advice from your local regulatory authorities.